research use only
Cat.No.S1006
| Related Targets | EGFR VEGFR JAK FGFR PDGFR HIF FLT3 HER2 FLT Bcr-Abl |
|---|---|
| Other Src Inhibitors | WH-4-023 PP2 (AGL 1879) SU6656 PP1 Src Inhibitor 1 UM-164 RK 24466 eCF506 Tolimidone (MLR-1023) 1-Naphthyl PP1(1-NA-PP1) |
|
In vitro |
DMSO
: 100 mg/mL
(184.49 mM)
Ethanol : 100 mg/mL Water : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Saracatinib (AZD0530) solubility in DMSO or water
Read more about Saracatinib (AZD0530) working concentrations for cell culture treatment
| Information | Saracatinib (AZD0530) is a potent, highly selective Src/Abl kinase inhibitor. It affects PI3K/AKT, Src/ERK, and JAK-STAT3 signaling pathways by blocking kinase activity and downstream phosphorylation, to inhibit tumor cell proliferation, migration, invasion, and fibrotic responses. |
|---|---|
|
Read more about Saracatinib (AZD0530) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
Read more about Saracatinib (AZD0530) Mechanism of Action Clinical Trials
| Molecular Weight | 542.03 | Formula | C27H32ClN5O5 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 379231-04-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | SMILES | CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl | ||
Read more about storage stability stock solution CAS number SMILES
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
What is its half-life?
Answer:
Based on the following paper, its half-life in vivo is around 40 hours and it reaches its peak level around 2–4 hours after dosing: http://clincancerres.aacrjournals.org/content/16/19/4876.long